- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2018
- Public Summary Document (PSD) November 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2018 PBAC Meeting - Word
Lenvatinib – November 2018
Lenvatinib: Capsule 4 mg (as mesilate); Lenvima®
Last updated
1 March 2019